Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...

Health NGO, Right to Care, highlights the urgent need for circumcision among boys aged 15 and older in KwaZulu-Natal to ...

Uganda's efforts to combat the HIV/AIDS epidemic have made significant strides, yet crucial gaps remain, particularly in preventing mother-to-child transmission of the virus.

Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...

“With low uptake of PrEP among the communities most impacted by HIV, this insurance coverage requirement with ... The new ...

The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Generic tenofovir disoproxil fumarate/emtricitabine the most frequently prescribed medication since 2021. (HealthDay News) — Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, ...

Gilead Sciences, Inc. GILD and partner Merck MRK announced new results from a mid-stage study evaluating the investigational ...

From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...